Business Context and Reporting Period
Company: Albemarle Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2004
Business Overview: Albemarle is a global developer, manufacturer, and marketer of specialty chemicals. Operations are reported in three segments: Polymer Additives, Catalysts, and Fine Chemicals. The reporting period is significantly impacted by the July 31, 2004, acquisition of the refinery catalysts business of Akzo Nobel N.V., which led to the creation of a new Catalysts segment.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2004 | Nine Months Ended Sep 30, 2004 | Nine Months Ended Sep 30, 2003 |
|---|---|---|---|
| Net Sales | $413.9 million | $1,062.7 million | $815.1 million |
| Operating Profit | $21.1 million | $70.6 million | $68.1 million |
| Net Income | $0.8 million | $35.2 million | $55.2 million |
| Diluted EPS | $0.02 | $0.83 | $1.31 |
| Cash and Equivalents | $60.8 million (Sep 30, 2004) | N/A | |
| Operating Cash Flow (9mo) | $131.2 million | $107.8 million | |
| Total Debt (Current + Long-term) | $953.3 million | $228.6 million (Dec 31, 2003) |
Margins: Gross profit margin for the nine months ended September 30, 2004, was 19.1%, down from 21.4% in the prior year period. Excluding $13.4 million in acquisition-related inventory step-up charges, the margin was 20.4%.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 49.7% in Q3 and 30.4% for the nine-month period compared to 2003, driven primarily by the Akzo Nobel acquisition and higher volumes/prices in Polymer Additives.
- Profitability Decline: Despite revenue growth, Net Income for the nine months dropped 36% to $35.2 million from $55.2 million in 2003. This was due to significant one-time charges and increased interest expenses.
- Debt Expansion: Total debt increased from $228.6 million at year-end 2003 to $953.3 million at September 30, 2004, to finance the $762.2 million Akzo Nobel acquisition.
- Segment Reorganization: The company reorganized into three segments (Polymer Additives, Catalysts, Fine Chemicals) following the acquisition, moving polyolefin catalysts from Polymer Chemicals to the new Catalysts segment.
Guidance, Outlook, and Risks
Management Commentary and Outlook
- Raw Material Costs: Management expects raw material and energy costs (excluding molybdenum) to increase approximately 8% and 9%, respectively, for the full year 2004 compared to 2003. Molybdenum prices surged from ~$8/lb to ~$24/lb, impacting the Catalysts segment.
- Price Increases: The company is seeking price increases across most product areas to offset inflation, with varying success.
- Catalysts Segment: Forecasted to add more than 35% to historic sales levels annually. Demand for hydroprocessing (HPC) and fluidized catalytic cracking (FCC) catalysts is expected to remain firm.
- Capital Expenditures: Full-year capital expenditures are forecasted to be about 50% greater than 2003 levels, funded by operating cash flow and borrowings.
Risks and Contingencies
- Acquisition Integration: Risks associated with integrating the Akzo Nobel refinery catalysts business.
- Legal Proceedings:
- Aventis Arbitration: Albemarle initiated arbitration against Aventis S.A. regarding indemnification for soil and groundwater contamination at a facility in Thann, France. Costs could be significant if indemnification is not granted.
- Insurance Dispute: A dispute with Amerisure Insurance regarding a water treatment venture withdrawal resulted in a $3.4 million valuation reserve charge.
- Environmental Liabilities: Recorded environmental liabilities are $28.5 million, with a reasonable possibility of additional costs up to $11.5 million.
Unusual Items
- Acquisition Charges: $13.4 million inventory step-up charge and $3.0 million in-process R&D write-off related to the Akzo Nobel deal.
- Hedging Losses: $12.8 million loss on euro-denominated hedging contracts for the acquisition purchase price.
- Insurance Settlement: $6.9 million gain from a settlement with a former insurer (partially offsetting costs).
Investor Verification Checklist
- Debt Covenants: Verify compliance with the new senior credit agreement covenants, specifically the fixed charge coverage ratio (must be ≥ 1.25:1) and debt-to-capitalization ratio (must be ≤ 65% initially, then 60%).
- Acquisition Accounting: Monitor the finalization of the purchase price allocation for the Akzo Nobel business, expected by Q2 2005.
- Molybdenum Pricing: Track the impact of volatile molybdenum prices on the Catalysts segment margins and the success of price pass-throughs to customers.
- Legal Outcomes: Review updates on the Aventis arbitration regarding the Thann facility environmental liabilities.
- Refinancing Plans: Confirm the execution of the proposed equity offering (up to $700 million shelf registration) to retire the $450 million 364-day bridge loan maturing in July 2005.